Fact check · Version 1 · Sources checked

“LL-37 is FDA-approved in the United States.”

The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.

Misleading

This statement leaves out a limit that changes its meaning.

No FDA-approved U.S. LL-37 drug was found when Drugs@FDA was checked for LL-37 and ropocamptide on August 30, 2026. An FDA chemical record identifies a substance. It does not mean that FDA approved a drug.

What this answer is based on
This answer uses an official regulator record or a specific product label.
Limits of this answer
United States approval status as reviewed August 30, 2026. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
Topic
Whether a specific product has an approval or another official status.

Sources for this fact check

Show 2 sources
Sources checked by
Site editor · Editorial review

More about LL-37

See the FDA and sports-rule status of LL-37

Other fact checks on LL-37